TrademarkDir
SPLIT MAZE
DEAD

Serial Number

75910735

Owner

Novasite Pharmaceuticals, Inc.

Attorney

CATHRYN A. CAMPBELL

First Use Date

Aug 28, 2002

Filing Date

Feb 2, 2000

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

SPLIT MAZE Trademark

Serial Number: 75910735 • Registration: 2737251

SPLIT MAZE is a trademark filed by Novasite Pharmaceuticals, Inc. on February 2, 2000. The trademark is classified under Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Novasite Pharmaceuticals, Inc. (4 trademarks)

3520 Dunhill Street
San Diego, CA 92121

Entity Type: 03

Trademark Details

Filing Date

February 2, 2000

Registration Date

July 15, 2003

First Use Anywhere

August 28, 2002

First Use in Commerce

August 28, 2002

Published for Opposition

June 5, 2001

Cancellation Date

February 20, 2010

Filing History

CANCELLED SEC. 8 (6-YR)
Feb 20, 2010 C8..
CASE FILE IN TICRS
Jun 23, 2008 CFIT
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Oct 18, 2006 ASCK
REGISTERED-PRINCIPAL REGISTER
Jul 15, 2003 R.PR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
May 14, 2003 CNPR
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 18, 2003 CRFA
PAPER RECEIVED
Apr 18, 2003 MAIL
NON-FINAL ACTION MAILED
Oct 15, 2002 CNRT
STATEMENT OF USE PROCESSING COMPLETE
Sep 24, 2002 SUPC
PAPER RECEIVED
Aug 30, 2002 MAIL
USE AMENDMENT FILED
Aug 28, 2002 IUAF
SOU EXTENSION 1 GRANTED
Mar 19, 2002 EX1G
PAPER RECEIVED
Mar 5, 2002 MAIL
SOU EXTENSION 1 FILED
Feb 28, 2002 EXT1
NOA MAILED - SOU REQUIRED FROM APPLICANT
Aug 28, 2001 NOAM
PUBLISHED FOR OPPOSITION
Jun 5, 2001 PUBO
NOTICE OF PUBLICATION
May 23, 2001 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 13, 2001 CNSA
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 23, 2001 CRFA
NON-FINAL ACTION MAILED
Jul 18, 2000 CNRT
ASSIGNED TO EXAMINER
Jul 7, 2000 DOCK
ASSIGNED TO EXAMINER
Jun 29, 2000 DOCK

Related Trademarks

More from this Owner

GENCHEM

GENCHEM

GENCHEM

GENCHEM

EXPANDED TARGET DRUG DISCOVERY

EXPANDED TARGET DRUG DISCOVERY

EXPANDED TARGET DRUG DISCOVERY

EXPANDED TARGET DRUG DISCOVERY

NOVASITE

NOVASITE

NOVASITE

NOVASITE